BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,255 | +8.1% | 11,450 | +4.6% | 0.00% | 0.0% |
| Q1 2023 | $36,307 | -64.3% | 10,950 | -25.5% | 0.00% | -62.5% |
| Q4 2022 | $101,610 | -97.1% | 14,690 | -67.4% | 0.01% | -97.3% |
| Q3 2022 | $3,538,000 | +8127.9% | 45,071 | +332.1% | 0.29% | +9633.3% |
| Q2 2022 | $43,000 | -24.6% | 10,430 | -11.8% | 0.00% | -25.0% |
| Q1 2022 | $57,000 | -58.7% | 11,830 | -14.5% | 0.00% | -55.6% |
| Q4 2021 | $138,000 | -89.5% | 13,830 | -69.4% | 0.01% | -89.8% |
| Q3 2021 | $1,310,000 | +92.4% | 45,234 | +766.4% | 0.09% | +95.6% |
| Q2 2021 | $681,000 | -41.7% | 5,221 | -83.7% | 0.04% | -45.8% |
| Q1 2021 | $1,168,000 | +276.8% | 32,023 | +930.7% | 0.08% | +295.2% |
| Q4 2020 | $310,000 | – | 3,107 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |